Cargando…

Inhibition of angiogenesis and tumour growth by VEGF121–toxin conjugate: differential effect on proliferating endothelial cells

Vascular endothelial growth factor (VEGF) plays an important role in tumour angiogenesis. VEGF binds to tyrosine kinase receptors, which are expressed almost exclusively on tumour endothelium. Therefore, VEGF can be used to target toxin molecules to tumour vessels for anti-angiogenic therapy. Howeve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wild, R, Dhanabal, M, Olson, T A, Ramakrishnan, S
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2000
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363558/ https://www.ncbi.nlm.nih.gov/pubmed/10993657 http://dx.doi.org/10.1054/bjoc.2000.1439

Ejemplares similares

VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours
por: Ohta, Y, et al.
Publicado: (1999)

The constitutive level of vascular endothelial growth factor (VEGF) is more important than hypoxia-induced VEGF up-regulation in the angiogenesis of human melanoma xenografts
por: Danielsen, T, et al.
Publicado: (2000)

Cytotoxicity of VEGF(121)/rGel on vascular endothelial cells resulting in inhibition of angiogenesis is mediated via VEGFR-2
por: Mohamedali, Khalid A, et al.
Publicado: (2011)

Encapsulated VEGF(121)-PLA microparticles promote angiogenesis in human endometrium stromal cells
por: Abraham, Sunil, et al.
Publicado: (2021)

Overexpression of VEGF(121), but not VEGF(165) or FGF-1, improves oxygenation in MCF-7 breast tumours
por: Fenton, B M, et al.
Publicado: (2004)

Effect of VEGF receptor inhibitor PTK787/ZK222548 combined with ionizing radiation on endothelial cells and tumour growth
por: Hess, C, et al.
Publicado: (2001)

Proliferation, bcl-2 expression and angiogenesis in pituitary adenomas: relationship to tumour behaviour
por: Turner, H E, et al.
Publicado: (2000)

VEGF(121)b, a new member of the VEGF(xxx)b family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo
por: Rennel, E S, et al.
Publicado: (2009)

VEGF(121)-Conjugated Mesoporous Silica Nanoparticle: A Tumor Targeted Drug Delivery System
por: Goel, Shreya, et al.
Publicado: (2014)

The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo
por: Zhang, H-T, et al.
Publicado: (2000)

VEGF(121)b and VEGF(165)b are weakly angiogenic isoforms of VEGF-A
por: Catena, Raúl, et al.
Publicado: (2010)

Blood flow influences vascular growth during tumour angiogenesis
por: Nasu, R, et al.
Publicado: (1999)

Interleukin-2 and histamine in combination inhibit tumour growth and angiogenesis in malignant glioma
por: Johansson, M, et al.
Publicado: (2000)

A novel targeted angiogenesis technique using VEGF conjugated magnetic nanoparticles and in-vitro endothelial barrier crossing
por: Arokiaraj, Mark Christopher
Publicado: (2017)

PDGF-BB regulates splitting angiogenesis in skeletal muscle by limiting VEGF-induced endothelial proliferation
por: Gianni-Barrera, R., et al.
Publicado: (2018)

Inhibitory Effects of Anti-VEGF Antibody on the Growth and Angiogenesis of Estrogen-induced Pituitary Prolactinoma in Fischer 344 Rats: Animal Model of VEGF-targeted Therapy for Human Endocrine Tumors
por: Miyajima, Katsuhiro, et al.
Publicado: (2010)

Prognostic value of vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinomas
por: Mineta, H, et al.
Publicado: (2000)

Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues
por: Akagi, K, et al.
Publicado: (2000)

Expression of vascular endothelial growth factor (VEGF) and its mRNA in uterine cervical cancers
por: Fujimoto, J, et al.
Publicado: (1999)

Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer
por: O'Byrne, K J, et al.
Publicado: (2000)

VEGF and Delta-Notch: interacting signalling pathways in tumour angiogenesis
por: Thurston, G, et al.
Publicado: (2008)

Production of VEGF and expression of the VEGF receptors Flt-1 and KDR in primary cultures of epithelial and stromal cells derived from breast tumours
por: Speirs, V, et al.
Publicado: (1999)

Impact of thymidine phosphorylase surexpression on fluoropyrimidine activity and on tumour angiogenesis
por: Marchetti, S, et al.
Publicado: (2001)

Molecular Characterization of EG-VEGF-mediated Angiogenesis: Differential Effects on Microvascular and Macrovascular Endothelial Cells
por: Brouillet, Sophie, et al.
Publicado: (2010)

VEGF-A121a binding to Neuropilins – A concept revisited
por: Sarabipour, Sarvenaz, et al.
Publicado: (2017)

EDIL3 and VEGF Synergistically Affect Angiogenesis in Endothelial Cells
por: Niu, Xuping, et al.
Publicado: (2023)

Endothelial FAK is required for tumour angiogenesis
por: Tavora, Bernardo, et al.
Publicado: (2010)

Endothelial FAK is required for tumour angiogenesis
por: Tavora, Bernardo, et al.
Publicado: (2016)

Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix
por: Loncaster, J A, et al.
Publicado: (2000)

Thiol-ene conjugation of VEGF peptide to electrospun scaffolds as potential application for angiogenesis
por: Yao, Tianyu, et al.
Publicado: (2022)

EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells
por: Jung, Y D, et al.
Publicado: (2001)

Vascular endothelial growth factor (VEGF) upregulates BCL-2 and inhibits apoptosis in human and murine mammary adenocarcinoma cells
por: Pidgeon, G P, et al.
Publicado: (2001)

The Effect and Mechanism of Vascular Endothelial Growth Factor (VEGF) on Tumor Angiogenesis in Gallbladder Carcinoma
por: XU, Dongqing, et al.
Publicado: (2019)

Vascular Endothelial Growth Factor-D (VEGF-D): An Angiogenesis Bypass in Malignant Tumors
por: Bokhari, Syeda Mahak Zahra, et al.
Publicado: (2023)

Mathematical and experimental analysis of localization of anti-tumour antibody–enzyme conjugates
por: Jackson, T L, et al.
Publicado: (1999)

Hypoxia-induced metastasis of human melanoma cells: involvement of vascular endothelial growth factor-mediated angiogenesis
por: Rofstad, E K, et al.
Publicado: (1999)

tmem33 is essential for VEGF-mediated endothelial calcium oscillations and angiogenesis
por: Savage, Aaron M., et al.
Publicado: (2019)

Does vascular endothelial growth factor (VEGF) predict local relapse and survival in radiotherapy-treated node-negative breast cancer?
por: Linderholm, B, et al.
Publicado: (1999)

Evaluation of recombinant human vascular endothelial growth factor VEGF121-loaded poly-l-lactide microparticles as a controlled release delivery system
por: ABRAHAM, Sunil, et al.
Publicado: (2020)

VEGF-A165 is the predominant VEGF-A isoform in platelets, while VEGF-A121 is abundant in serum and plasma from healthy individuals
por: Yamakuchi, Munekazu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9po2ukbt28vchigv9vq188sg93